[1. Cancer in Slovenia 2010. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2011. p. 37.]Search in Google Scholar
[2. Cancer Research UK. Statistical Information Team; 2012. Available at: http:/ www.info.cancerresearchuk.org/cancerstats]Search in Google Scholar
[3. United States cancer statistics: 1999-2008 incidence and mortality Wbbased report. Atlanta (GA): Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2010. Available at: http://www.cdc.fov/uscs]Search in Google Scholar
[4. Zhang B, Cai FF, Zhong XY. An overview of biomarkers for the ovarian cancer diagnosis. Eur J Obstet Gynecol Reprod Biol 2011; 158: 119-23.10.1016/j.ejogrb.2011.04.023]Search in Google Scholar
[5. Lalwani N, Prasad SR, Vikram R, Shanbhogue AK, Huetter PC, Fasih N. Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radio Graphics 2011; 31: 625-46.10.1148/rg.313105066]Search in Google Scholar
[6. Paulsen T, Kærn J, Kiærheim K, Tropé C, Tretli S. Symptoms and referral of women with epithelial ovarian tumors. Int J Gynecol Obstet 2005; 88: 31-7.10.1016/j.ijgo.2004.09.008]Search in Google Scholar
[7. Wikborn C, Pettersson F, Silfverswärd C, Moberg PJ. Symptoms and diagnostic difficulties in ovarian epithelial cancer. Int J Gynecol Obstet 1993; 42: 261-4.10.1016/0020-7292(93)90222-I]Search in Google Scholar
[8. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systemetis review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 1998; 105: 493-9.10.1111/j.1471-0528.1998.tb10148.x]Search in Google Scholar
[9. Takač I, Arko D. Diagnosis and treatment of ovarian cancer. In: Štabuc B, editor. Gynecological cancer/ XVI. Course in memoriam dr. Dušana Reje. Ljubljana: Zveza slovenskih društev proti raku; 2008. p. 41-8.]Search in Google Scholar
[10. Benedet JL. Progres in gynecologic cancer detection and treatment. Int J Gynecol Obstet 2000; 70: 135-47.10.1016/S0020-7292(00)00232-0]Search in Google Scholar
[11. Bolton KL, Ganda C, Berchuck A, Pharaoh PDP, Gayther SA. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC). J Intern Med 2012; 271: 366-78.10.1111/j.1365-2796.2011.02509.x]Search in Google Scholar
[12. Zweemer RP, Verheijen RHM, Menko FH. Differences between hereditary and sporadic ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999; 82: 151-3.10.1016/S0301-2115(98)00218-8]Search in Google Scholar
[13. Peker I, Kaya E. Darendeliler-Yaman S. Clinic and radiographical evaluation of non - syndromic hypodontia and hyperdontia in permanent dentition. Med Oral Patol Oral Cir Bucal 2009; 14: 393-7.]Search in Google Scholar
[14. Silva Meza R. Radiographic assessment of congenitally missing teeth in orthodontic patients. Int J Pediatr Dent 2003; 13: 112-6.10.1046/j.1365-263X.2003.00436.x12605629]Search in Google Scholar
[15. Pemberton TJ, Das P, Patel PI. Hypodontia: genes and future perspectives. Braz J Oral Sci 2005; 4: 695-706.]Search in Google Scholar
[16. Mattheeuws N, Dermaut L, Martens G. Has hypodontia increased in Caucasians during the 20th century? A meta-analysis. Eur J Orthod 2004; 26: 99-103.10.1093/ejo/26.1.9914994889]Search in Google Scholar
[17. Poldner BJ, Van’t Hof MA, Van der Linden FP, Kuijpers Jagtmas AM. A meta-analysis of the prevalence of dental agenesis of permenent teeth. Community Dent Oral Epidemiol 2004; 32: 217-26.10.1111/j.1600-0528.2004.00158.x]Search in Google Scholar
[18. Peck L, Peck S, Attia Y. Maxillary canine-first premolar transposition, associated dental anomalies and genetic basis. Angle Orthod 1993; 63: 99-109.]Search in Google Scholar
[19. Thesleff I. Epithelial-mesenhymal signalling regulating tooth morphogenesis. J Cell Science 2003; 116: 1647-8.10.1242/jcs.00410]Search in Google Scholar
[20. Mostowska A, Biedziak B, Jagodzinski PP. Axis inhibition protein 2 (AXIN2) polymorphisms may be a risk factor for selective tooth agenesis. J Hum Genet 2006; 51: 262-6.10.1007/s10038-005-0353-6]Search in Google Scholar
[21. Lammi L, Arte S, Somer M, Järvinen H, Lahermo P, Thesleff I, et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 2004; 74: 1043-50.10.1086/386293]Search in Google Scholar
[22. Schmid S, Bieber M, Zhang F, Zhang M, He B, Jablons D, et al. Wnt and Hedgehog gene pathway expression in serous ovarian cancer. Int J Gynecol Cancer 2011; 21: 975-80.10.1097/IGC.0b013e31821caa6f]Search in Google Scholar
[23. Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 2001; 61: 8247-55.]Search in Google Scholar
[24. Benedet JL. Staging classifications and practice guidelines for gynecologic cancer. Int J Gynecol Obstet 2000; 70: 207-312.10.1016/S0020-7292(00)00300-3]Search in Google Scholar
[25. Lopes NN, Petrilli AS, Caran Em, França CM, Chilvarquer I, Lederman H. Dental abnormalities in children submitted to antineoplastic therapy. J Dent Child 2006; 73: 210-3.]Search in Google Scholar
[26. Küchler EC, Lips A, Tannure PN, Ho B, Costa MC, Granjeiro JM, et al. Tooth agenesis association with self-reported family history of cancer. J Dent Res 2013; 92: 149-55.10.1177/0022034512468750]Search in Google Scholar
[27. Zhai Y, Wu R, Schwartz DR, Darrah D, Reed H, Kolligs FT, et al. Role of ß- Catenin /T- Cell Factor-regulate genes in ovarian endometrioid adenocarcinoma. Am J Pathol 2002; 160: 1229-38.10.1016/S0002-9440(10)62550-3]Search in Google Scholar
[28. Chalothorn LA, Beeman CS, Ebersole JL, Kluemper GT, Hicks EP, Kryscio RJ, et al. Hypodontia as a risk marker for epithelial ovarian cancer: a casecontroled study. J Am Dent Assoc 2008; 139: 163-9.10.14219/jada.archive.2008.013218245684]Search in Google Scholar
[29. Fekonja A. Hypodontia prevalence over four decades in Slovenian population. J Esthet Restor Dent 2013; doi: 10.1111/jerd.12076. [Epub ahead of print].10.1111/jerd.1207624341573]Search in Google Scholar
[30. Lurie G, Wilkens LR, Thompson PJ, Matsuno RK, Carney ME, Goodman MT. Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis. Gynecol Oncol 2010; 119: 278-84.10.1016/j.ygyno.2010.05.028294968220591474]Search in Google Scholar
[31. But I. DNA ploidy and CA 125 in serous ovarian carcinoma [Doctoral Thesis]. Ljubljana: Faculty of Medicine, University of Ljubljana; 1998. ]Search in Google Scholar